Edwards Lifesciences Inc. (NYSE:EW) scooped up Embrella Cardiovascular for a cool $43 million.
Wayne, Pa.-based Embrella makes embolic protection devices used in coronary procedures such as transcatheter valve replacements. Edwards officials said the deal, which closed March 11, will bolster the company’s position in the hot transcatheter valve market.